The global viscosupplementation market revenue was around US$ 4.8 billion in 2022 and is estimated to reach US$ 10.8 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.5% during the forecast period from 2023 to 2031.
Viscosupplementation is a minimally invasive treatment choice for osteoarthritis patients. A patient receiving viscosupplementation has an injection of hyaluronic acid into their knee joint. Hyaluronic acid is a lubricant that occurs naturally and is found in high concentrations in the fluids of the eyes and joints. This liquid is essential for reducing pain and inflammation in arthritic joints such as the knee.
Market Driving Factors
The surge in the prevalence of obesity drives the market growth. For instance, in March 2022, according to the World Obesity Federation, by 2030, it is projected that one billion people worldwide will suffer from obesity. It causes severe joint issues since joint pain is remarkably associated with body weight and being overweight raises the pressure on joints, especially on knees, which can break down the cartilage.
The surge in the geriatric population with severe arthritis boosts the market growth. Increasing age brings lots of health problems in elderly people. One of the most common problems they face is bone and joint-related issues such as osteoporosis, osteoarthritis, and others that cause difficulty moving walking problems, and so on. In addition, a large number of elderly people become completely dependent on personal mobility devices due to the difficulty of small transportation which further raises the expense of these devices. It is a well-known fact that joint movement becomes less stiffer and more flexible as the person ages.
The high price of hyaluronic acid and the existence of alternatives for knee osteoarthritis treatment are some factors that hamper the market growth.
Regional Analysis
North America dominated the market and is estimated to continue its trends over the forecast period. The existence of well-established healthcare infrastructure and cutting-edge medical facilities, the increasing prevalence of osteoarthritis and joint-related disorders, and a strong focus on research and development activities in the field of orthopedics majorly fuel the market growth.
Asia Pacific dominates the market. This is because of factors such as the increasing prevalence of osteoarthritis and joint disorders owing to varying lifestyles and the aging population, the rise in healthcare expenditure, and enhancing healthcare infrastructure in emerging economies. Furthermore, the increasing awareness and adoption of cutting-edge treatment options in orthopedic care and the multinational pharmaceutical companies' expansion in the region offer access to a broad range of viscosupplementation products. Thus, this factor drives the market growth in the region.
Segmentation Insights
Type Insight
The single injection viscosupplementation segment dominates the market. This is due to the increasing number of product launches for single injection viscosupplementation and lower injection volume makes the administration of single injection viscosupplementation easier for healthcare professionals and more comfortable for patients. Additionally, an increase in the adoption of key strategies such as partnership, collaboration, and agreement by key players for viscosupplementation products is predicted to drive market growth.
Application Insight
The knee osteoarthritis segment dominated the market. This can be attributed to the existence of knee osteoarthritis and the increasing geriatric population who are more sensitive to knee osteoarthritis. In addition, the aging population is more vulnerable to knee osteoarthritis owing to the aging effect, which lowers the level of water contained in cartilage and further reduces its ability to absorb shock and cushion.
Distribution Channel Insight
The hospital pharmacies segment dominates the market. This is because increase in the number of hospitals and a surge in expenditure by the government to develop healthcare infrastructure. Additionally, a rise in the prevalence of knee osteoarthritis is anticipated to drive the segment growth.
Prominent Companies
Segmentation Outline
The global viscosupplementation market segmentation focuses on Type, Application, Distribution Channel, and Region.
By Type
By Application
By Distribution Channel
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL VISCOSUPPLEMENTATION MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: VISCOSUPPLEMENTATION MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL VISCOSUPPLEMENTATION MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL VISCOSUPPLEMENTATION MARKET, BY TYPE
5.1 OVERVIEW
5.2 SINGLE INJECTION VISCOSUPPLEMENTATION
5.3 THREE INJECTION VISCOSUPPLEMENTATION
5.4 FIVE INJECTION VISCOSUPPLEMENTATION
6 GLOBAL VISCOSUPPLEMENTATION MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 KNEE OSTEOARTHRITIS
6.2.1 GENDER
6.2.1.1 MALE
6.2.1.2 FEMALE
6.3 HIP OSTEOARTHRITIS
6.4 HAND OSTEOARTHRITIS
7 GLOBAL VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL
7.1 OVERVIEW
7.2 HOSPITAL PHARMACIES
7.3 RETAIL PHARMACIES
7.4 ONLINE PHARMACIES
8 GLOBAL VISCOSUPPLEMENTATION MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL VISCOSUPPLEMENTATION MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 BIOVENTUS
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 ANIKA THERAPEUTICS INC
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 MIRAVO HEALTHCARE
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 LG LIFE SCIENCES LTD
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 SEIKAGAKU CORPORATION
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 APTISSEN
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 SANOFI
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 CHUGAI PHARMACEUTICAL CORP
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 AVANOS MEDICAL INC
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 FIDIA FARMACEUTICI S.P.A
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved